Pyrimethamine: Difference between revisions
From IDWiki
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
* Monitoring |
* Monitoring |
||
** CBC q2d initially, then decreasing frequency |
** CBC q2d initially, then decreasing frequency |
||
[[Category:Antibiotics]] |
|||
Latest revision as of 19:10, 20 August 2020
- Antimicrobial that inhibits the reduction of dihydrofolic to tetrahydrofolic acid
- Indications include toxoplasmosis and malaria
- Major adverse effects is bone marrow suppression, so need to monitor CBC
- Pancytopenia, which is reversible with leucovorin
- GI intolerance
- Other: rash, hepatitis, headache, dizziness, insomnia
- Monitoring
- CBC q2d initially, then decreasing frequency
